Navigation Links
Jury Rules in Favor of Glycoproducts International, Inc.
Date:5/28/2008

RIGGINS, Idaho, May 28 /PRNewswire/ -- Glycoproducts International, Inc., a provider of nutritional supplement products, today announced that a federal court jury sitting in the Northern District of Texas returned a mixed verdict relating to claims that Glycoproducts International, Inc. committed patent infringement of two of Mannatech, Incorporated's (Nasdaq: MTEX) patents relating to Mannatech's AMBROTOSE(R) technology.

The jury ruled in favor of Glycoproducts International, Inc., finding that they were innocent of patent infringement of Mannatech's U.S. Patent No. 6,929,807, the parent patent upon which the lawsuit against Glycoproducts International, Inc. was originally based. However, in regard to Mannatech's continuation patent of the parent patent, U.S. Patent No. 7,157,431, which was issued and first claimed to be infringed by Mannatech after the lawsuit was filed, the jury found that Glycoproducts International, Inc. had committed patent infringement.

The jury ruled in favor of Mannatech on its claims of infringement of the AMBROTOSE(R) trademark. Since Glycoproducts International, Inc. successfully defended its position against Mannatech's '807' parent patent, it will oppose Mannatech's request for an injunction to prohibit Glycoproducts International, Inc. from further production, distribution and sale of its Glycomannan(R) product.

Phil Moulton, president of Glycoproducts International, Inc. said, "Our product is distinctly different from Mannatech's products, and is a source of at least 10 of the 11 scientifically recognized biologically vital sugars, with minerals, bioflavonoids and other nutrients that naturally occur within the whole-food matrix."

"Our products are derived from natural sources and are not diluted with rice fillers," he stated.

The verdict was delivered on Friday, May 9, 2008, in the United States District Court for the Northern District of Texas, Dallas Division, following testimony before Federal Magistrate Jeff Kaplan. Glycoproducts International, Inc. (formerly Glycobiotics International, Inc.) was represented by Attorney William G. Shaw, Jr., of Collins, Basinger & Pullman, P.C.


'/>"/>
SOURCE Glycoproducts International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Consumer Watchdog Raises Concern That Health Policy Cancellation Rules Have Been Derailed in Deal With Kaiser
2. Oregon Supreme Court Rules in Favor of R.J. Reynolds Tobacco Company in Medical Monitoring Suit
3. Virginia Judge Rules Medical Device Pioneer Committed Malpractice
4. DARA Announces Information in Compliance with NASDAQ Rules
5. MedApps Wins Nokia 2008 Mobile Rules! Business Plan Competition Award
6. MedCom Announces Court Rules Card Activation Technologies Patent Is Valid
7. VIDEO from Medialink and The Childrens Hospital of Philadelphia: New Research - Rules of the Road for Teens and Passengers
8. When the rules of the game are broken: Research studies sports injuries related to illegal activity
9. IHF Says Google Personal Health-Records System Gives Consumers Greater Control Over Privacy than HIPAA Rules
10. Aetna Requires CAQH Core Rules Certification for Vendors
11. CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: